Graft-vs-host disease after small bowel transplantation in children |
| |
Authors: | Ane M. Andres,Manuel Lopez Santamarí a,Esther Ramos,Jesus Sarriá ,Manuel Molina,Francisco Hernandez,Jose L. Encinas,Javier Larrauri,Gerardo Prieto,Juan Antonio Tovar |
| |
Affiliation: | Department of Pediatric Surgery, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain |
| |
Abstract: |
PurposeGraft-vs-host disease (GVHD) is a rare complication of transplantation of organs rich in immunocompetent cells. The goal of this study was to report the features of GVHD after small bowel transplantation (SBTx) in children.MethodsThe study involved a retrospective review of patients undergoing SBTx between 1999 and 2009 who had GVHD.ResultsOf 46 children receiving 52 intestinal grafts (2 liver-intestine and 3 multivisceral), 5 (10%) developed GVHD. Median age at transplant was 42 (19-204) months. Baseline immunosupression consisted of tacrolimus and steroids supplemented with thymoglobulin (n = 2) or basiliximab (n = 3) for induction. Median time between transplantation and GVHD was 47 (16-333) days. All patients had generalized rash, 2 had diarrhea, and 2 had respiratory symptoms. Other symptoms were glomerulonephritis (n = 1) and conjunctivitis (n = 1). Four developed severe hematologic disorders. The diagnosis was confirmed by skin biopsy in 4 patients and supported by chimerism studies in two. Colonoscopy and opthalmoscopic findings were also suggestive in one. Treatment consisted of steroids and decrease of tacrolimus, with partial response in four. Other immunosuppressants were used in refractory or recurrent cases. Three patients died within 4 months after diagnosis.ConclusionGraft-vs-host disease is a devastating complication of SBTx, with high mortality probably associated with severe immunologic dysregulation. |
| |
Keywords: | Small bowel transplantation Graft-vs-host disease |
本文献已被 ScienceDirect 等数据库收录! |
|